News and Events

• 

  October 2026: Bringing Hope and Clinical Trial Access to Patients with Gynecologic Carcinosarcoma 

  Thanks to the generosity of countless supporters for the past ten years in honor of founder Diane Redington, The GCS Project is helping change what is possible for women battling… Read More »

  ---

• 

  (VELA) Study of BLU-222 in Advanced Solid Tumors | Identifier: NCT05252416

  Clinical trials are currently being offered at the University of Arkansas for Medical Sciences (UAMS). Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single… Read More »

  ---

• 

  A Phase Ib/II Single Arm Study of Cabozantinib Plus Dostarlimab in Women With Recurrent Gynecologic Carcinosarcoma | Identifier: NCT05559879

  Clinical trials are currently being offered at the University of Alabama at Birmingham. Immunotherapy has gained a significant amount of attention recently, but its efficacy as a single agent in… Read More »

  ---